Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2026 Financial Results

– Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome; Primary and Key Secondary Endpoints Achieved…